Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Ozempic has taken over the entertainment space, allowing several celebrities who were known to be heavier to show off slimmer ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people ...

The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a ...

Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...

Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...

Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication often sold under the brand ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...